Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib

Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin Hyun, Park, Hyunkyung, Kim, Ki Hwan, Kim, Jin-Soo, Choi, In Sil, Roh, Eun Youn, Kim, Ji Eun, Chang, Mee Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043942/
https://www.ncbi.nlm.nih.gov/pubmed/32140274
http://dx.doi.org/10.4048/jbc.2020.23.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043942/
https://www.ncbi.nlm.nih.gov/pubmed/32140274
http://dx.doi.org/10.4048/jbc.2020.23.e1

Ejemplares similares